1. 1.DATABASE construction  n=1,715  Median OS=40.0 months, age: 64+/-10 yrs  Histology (adeno/squamous/large): 50% / 45% / 5%  Stage 1/2/3/4: 63% / 27% / 10% / 1% 2.META-ANALYSIS of biomarker candidates  Biomarker candidates identified in Pubmed n=22  For each gene the exact conditions in which it was identified have been retrieved, and these have been used as filtering when selecting the patients for the survival analysis.  Of the 22, the best performing genes are: n(1): number of patients in original study, n(2): number of patients in the KM-plotter, HR: hazard ratio, ADE: adenocarcinoma, NSCLC: all non-small-cell lung cancer patients 3.Selected KAPLAN-MEIER plots (table: *) An online tool for the validation of survival-predicting biomarkers in non small-cell lung cancer using microarray data of 1,329 1,715 patients Background and Objective Materials & Methods Results Web addresses Summary Grant support: OTKA PD 83154, PREDICT 259303 (EU Health.2010.2.4.1.-8), KTIA EU_BONUS_12-1-2013-0003, Alexander von Humboldt-Foundation Grant support: OTKA PD 83154, PREDICT 259303 (EU Health.2010.2.4.1.-8), KTIA EU_BONUS_12-1-2013-0003, Alexander von Humboldt-Foundation Balázs Győrffy and András Lánczky Research Laboratory for Pediatrics and Nephrology, Hungarian Academy of Sciences and Semmelweis University 1st Dept. of Pediatrics, Budapest, Hungary SymbolReferencen(1)Cohortn(2)HRp value VEGFZhan et al 20095386NSCLC14041.93.3e-10 Cyclin EHuang et al 20122606NSCLC14041.592.3e-09* ADE4862.444.8e-08 CDK1Zhang et al 2012a2731NSCLC14042.56<1e-16* CADM1Botling et al 2012617ADE4860.387e-12* CDKN2AJin et al 2001106NSCLC14041.651.8e-09 CD24Lee et al 2010267ADE4862.453.6e-10 ERCC1Simon et al 200551NSCLC14041.651.4e-10 1.DATABASE construction  Repositories: GEO, TCGA, ArrayExpress, caBIG  Platforms: Affymetrix HGU133A, plus2 & A 2.0 arrays  at least 30 patients with survival information  MAS5 normalization + quality control 2.SURVIVAL analysis  Kaplan-Meier plot  „survival” Bioconductor package  Cox univariate + multivariate analysis 3.ONLINE platform  Apache web server on Debian Linux  script developed in PHP  Open access at: www.kmplot.com/lung 4.META-analysis  Pubmed search of published biomarkers  Best cutoff selection: each percentile (of expression) between the lower and upper quartiles are computed and the best performing threshold is used as the final cutoff in the Cox regression analysis. 1.optimized treatment for non-small cell lung cancer had lead to improved prognosis, but the overall survival is still very short 2.by identifying biomarkers related to survival we can further understand the molecular basis of the disease OBJECTIVE: we present the development of an online available tool suitable for the real-time meta-analysis of published lung cancer microarray datasets to identify biomarkers related to survival  we performed a meta-analysis of survival-associated genes  an integrated database and an online tool for future in silico validation of new candidates has been established Online access: http://www.kmplot.com/lunghttp://www.kmplot.com/lung Group homepage: http://gyer1-6.sote.hu/gyorffyhttp://gyer1-6.sote.hu/gyorffy Contact: gyorffy@kmplot.com Cyclin E1CDK1CADM1